• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Rxsight Inc (NQ: RXST )

    46.94 -2.84 (-5.71%)
    Streaming Delayed Price Updated: 11:47 AM EDT, Jul 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 356,274
    Open 50.39
    Bid (Size) 46.92 (1)
    Ask (Size) 47.01 (6)
    Prev. Close 49.78
    Today's Range 46.34 - 51.30
    52wk Range 20.66 - 66.54
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    RxSight, Inc. To Participate in the Truist Securities Medtech Conference
    From RxSight, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +28.07%
    +28.07%
    1 Month
    -18.40%
    -18.40%
    3 Month
    -15.14%
    -15.14%
    6 Month
    -0.18%
    -0.18%
    1 Year
    +52.69%
    +52.69%

    More News

    Read More
    Do You Have Your Eye On Vision Care Stocks?
    Via Talk Markets
    Why RxSight (RXST) Shares Are Falling
    Via Benzinga
    What 10 Analyst Ratings Have To Say About RxSight
    Via Benzinga
    Assessing RxSight: Insights From 8 Financial Analysts
    Via Benzinga
    RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. Announces Pricing of Public Offering of Common Stock
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. Announces Proposed Public Offering of Common Stock
    From RxSight, Inc.
    Via GlobeNewswire
    Forecasting The Future: 9 Analyst Projections For RxSight
    Via Benzinga
    RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    RxSight, Inc. Reports First Quarter 2024 Financial Results
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. to Present at the Bank of America Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    Recap: RxSight Q4 Earnings
    Via Benzinga
    RxSight's Earnings Outlook
    Via Benzinga
    Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
    Via Benzinga
    RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    Chart Of The Day: RxSight - Cashing In On Cataracts
    Via Talk Markets
    RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
    From RxSight, Inc.
    Via GlobeNewswire
    Earnings Scheduled For February 28, 2024
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.